Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419059969> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2419059969 endingPage "35" @default.
- W2419059969 startingPage "127" @default.
- W2419059969 abstract "Thirty-six patients with hepatitis C virus-RNA positive chronic hepatitis were studied to evaluate whether recombinant alpha-2b interferon, in medium-high doses, (6-9 MU 3 times/week) over a long period (12-18 months), was more effective in reducing or normalizing alanine aminotransferase values, and in reducing the relapsing percentage than the historical trials. At the end of the 12th and 18th month of treatment, mean alanine aminotransferase values were significantly reduced; the level of complete responses was 36.1%, at the end of the 12th month, and 19.4% at the end of the 18th month (intention to treat). These results were no better than comparable findings in the literature. At the end of the first follow-up (12th month), percent complete responses fell to 15.5%, with a relapse rate of 14.3%. At the end of the second follow-up (24th month), percent complete responses fell further to 11.1% (all 4 patients with a 24 months sustained response showed absence of viraemia), with a relapse rate of 42.9%; even these percentages were judged unsatisfactory. In conclusion, no significant advantage was obtained by prolonging interferon treatment and/or using higher dosages. However, the possible virus clearance in all the long-term responders seems to justify further investigation in terms of cost-benefit analysis." @default.
- W2419059969 created "2016-06-24" @default.
- W2419059969 creator A5025224549 @default.
- W2419059969 creator A5049136496 @default.
- W2419059969 creator A5049932119 @default.
- W2419059969 creator A5057482109 @default.
- W2419059969 creator A5058265501 @default.
- W2419059969 creator A5065919385 @default.
- W2419059969 creator A5076518306 @default.
- W2419059969 creator A5088637026 @default.
- W2419059969 date "1996-04-01" @default.
- W2419059969 modified "2023-09-27" @default.
- W2419059969 title "Prolonged treatment of chronic C hepatitis by means of medium-high doses of recombinant alpha-2b interferon: an open study to evaluate response and long-term relapse." @default.
- W2419059969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8789822" @default.
- W2419059969 hasPublicationYear "1996" @default.
- W2419059969 type Work @default.
- W2419059969 sameAs 2419059969 @default.
- W2419059969 citedByCount "0" @default.
- W2419059969 crossrefType "journal-article" @default.
- W2419059969 hasAuthorship W2419059969A5025224549 @default.
- W2419059969 hasAuthorship W2419059969A5049136496 @default.
- W2419059969 hasAuthorship W2419059969A5049932119 @default.
- W2419059969 hasAuthorship W2419059969A5057482109 @default.
- W2419059969 hasAuthorship W2419059969A5058265501 @default.
- W2419059969 hasAuthorship W2419059969A5065919385 @default.
- W2419059969 hasAuthorship W2419059969A5076518306 @default.
- W2419059969 hasAuthorship W2419059969A5088637026 @default.
- W2419059969 hasConcept C104317684 @default.
- W2419059969 hasConcept C126322002 @default.
- W2419059969 hasConcept C141071460 @default.
- W2419059969 hasConcept C162156334 @default.
- W2419059969 hasConcept C185592680 @default.
- W2419059969 hasConcept C203014093 @default.
- W2419059969 hasConcept C2522874641 @default.
- W2419059969 hasConcept C2776029263 @default.
- W2419059969 hasConcept C2776178377 @default.
- W2419059969 hasConcept C2776408679 @default.
- W2419059969 hasConcept C2776694085 @default.
- W2419059969 hasConcept C2781228144 @default.
- W2419059969 hasConcept C2909179924 @default.
- W2419059969 hasConcept C3019096185 @default.
- W2419059969 hasConcept C3020491458 @default.
- W2419059969 hasConcept C40767141 @default.
- W2419059969 hasConcept C55493867 @default.
- W2419059969 hasConcept C71924100 @default.
- W2419059969 hasConcept C90924648 @default.
- W2419059969 hasConceptScore W2419059969C104317684 @default.
- W2419059969 hasConceptScore W2419059969C126322002 @default.
- W2419059969 hasConceptScore W2419059969C141071460 @default.
- W2419059969 hasConceptScore W2419059969C162156334 @default.
- W2419059969 hasConceptScore W2419059969C185592680 @default.
- W2419059969 hasConceptScore W2419059969C203014093 @default.
- W2419059969 hasConceptScore W2419059969C2522874641 @default.
- W2419059969 hasConceptScore W2419059969C2776029263 @default.
- W2419059969 hasConceptScore W2419059969C2776178377 @default.
- W2419059969 hasConceptScore W2419059969C2776408679 @default.
- W2419059969 hasConceptScore W2419059969C2776694085 @default.
- W2419059969 hasConceptScore W2419059969C2781228144 @default.
- W2419059969 hasConceptScore W2419059969C2909179924 @default.
- W2419059969 hasConceptScore W2419059969C3019096185 @default.
- W2419059969 hasConceptScore W2419059969C3020491458 @default.
- W2419059969 hasConceptScore W2419059969C40767141 @default.
- W2419059969 hasConceptScore W2419059969C55493867 @default.
- W2419059969 hasConceptScore W2419059969C71924100 @default.
- W2419059969 hasConceptScore W2419059969C90924648 @default.
- W2419059969 hasIssue "3" @default.
- W2419059969 hasLocation W24190599691 @default.
- W2419059969 hasOpenAccess W2419059969 @default.
- W2419059969 hasPrimaryLocation W24190599691 @default.
- W2419059969 hasRelatedWork W1996352524 @default.
- W2419059969 hasRelatedWork W2016676811 @default.
- W2419059969 hasRelatedWork W2020081463 @default.
- W2419059969 hasRelatedWork W2053532629 @default.
- W2419059969 hasRelatedWork W2071402271 @default.
- W2419059969 hasRelatedWork W2143885609 @default.
- W2419059969 hasRelatedWork W2341014604 @default.
- W2419059969 hasRelatedWork W2341829866 @default.
- W2419059969 hasRelatedWork W2468074350 @default.
- W2419059969 hasRelatedWork W3665843 @default.
- W2419059969 hasVolume "28" @default.
- W2419059969 isParatext "false" @default.
- W2419059969 isRetracted "false" @default.
- W2419059969 magId "2419059969" @default.
- W2419059969 workType "article" @default.